Open original FDA record ↗Recall record
- FDA identifier
- Z-0694-2022
- Company in FDA record
- ev3 Inc.
- FDA classification date
- Mar 7, 2022
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class I
Reason stated in the source
The device has similarities in design to another device that the firm recently issued a field correction on due to instances of tip detachment and embolization.
Source facts
- Action
- The recalling firm began issuing the URGENT MEDICAL DEVICE NOTICE dated February 2022 on 2/4/2022 via 2-day UPS delivery. The letter explained the issue and instructed the consignee to adhere to the existing IFU instructions and warnings and precautions listed in the letter to reduce the risk of guidewire prolapse. The Customer Instructions included the notice was to be shared with all who needed to be aware within the consignee's organization or to any other organization where the product has been transferred; to review the IFU included with the product prior to use, noting the warnings and precautions listed in the notice; and to complete the Customer Confirmation Form to acknowledge receipt of the notice and that the appropriate action has been taken. It was to be emailed to the recalling firm.
- Initiated
- 2022-02-04
- Root cause
- Labeling design
- Terminated
- 2024-10-02
- Distribution
- US Nationwide distribution in the states of AZ, CA, FL, IA, IL, KS, LA, MI, MS, NC, NJ, NY, OR, SC, SD, TN, TX, and VA.
- Recall number
- Z-0694-2022
- Recall status
- Terminated
- CDRH record ID
- 191704
- FDA classified
- 2022-03-07
- Recall event number
- 89470